Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Board outcome of Board meeting held on January 02, 2026.

Listed-company acquisitionStrategic Transactions View source PDF Explain this filing

GKSL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.2%Reaction day

₹103.51

prior close

₹103.77

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.9%-2.1% vs market

Hospital peers, median of 21sector+0.8%-2.0% vs sector

On the reaction day the stock moved 2.1 pts less than Nifty Microcap 250 and 2.0 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

+0.4

15m

+0.1

30m

+0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.2+0.9-2.1+0.8-2.0

Next day

-1.0+1.2-2.2-0.3-0.7

-2.9+0.5-3.4+0.4-3.2

-0.3+0.5-0.8-0.6+0.3

-1.0-1.4+0.4-1.6+0.7

-1.7-3.1+1.4-2.9+1.2

+1.0-3.6+4.5-2.4+3.4

15d

-3.4-9.0+5.6-9.4+6.0

+1.2-7.0+8.3-8.5+9.7

+6.7-7.8+14.5-10.3+16.9

-0.5-11.9+11.4-12.5+12.0

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 21Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Gujarat Kidney and Super Speciality Limited has approved the acquisition of a 100% equity stake in Parekhs Hospital Private Limited, an Ahmedabad-based medical and healthcare service provider, making it a wholly owned subsidiary. The deal is a cash transaction valued at Rs. 77 crore, for all 2,55,000 equity shares of the target company. Parekhs Hospital had a turnover of approximately Rs. 25.67 crore in FY2024-25, with stable revenues of around Rs. 24-26 crore over the last three financial years. The acquisition is not a related party transaction and is expected to be completed in about 2 months. The move is aimed at strengthening the company's presence in the healthcare sector and diversifying its business portfolio.

Likely market impact

This acquisition will expand Gujarat Kidney's healthcare footprint and add a new wholly owned subsidiary, though the Rs. 77 crore cash outflow is a sizable commitment. Shareholders should watch for completion timelines and integration updates.